US Stock MarketDetailed Quotes

Orchestra BioMed (OBIO)

Watchlist
  • 3.970
  • -0.020-0.50%
Close May 1 15:59 ET
  • 3.970
  • 0.0000.00%
Post 16:10 ET
237.73MMarket Cap-3.58P/E (TTM)

Orchestra BioMed (OBIO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.15%-48.96M
83.23%-2.27M
-6.20%-14.55M
-52.14%-15.53M
-26.70%-16.62M
-9.61%-50.56M
-23.36%-13.54M
-33.24%-13.7M
2.71%-10.21M
8.81%-13.11M
Net income from continuing operations
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
Operating gains losses
---254K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
6.17%327K
-2.38%82K
6.58%81K
9.46%81K
12.16%83K
7.32%308K
16.67%84K
7.04%76K
1.37%74K
4.23%74K
Other non cash items
757.92%2.06M
19.52%1.19M
957.33%643K
194.84%147K
115.46%81K
107.80%240K
308.82%994K
91.35%-75K
82.12%-155K
39.42%-524K
Change In working capital
-1,255.82%-10.37M
-801.03%-12.28M
497.65%2.54M
-88.34%358K
46.02%-990K
76.87%-765K
-1,075.00%-1.36M
-204.24%-639K
401.80%3.07M
58.47%-1.83M
-Change in receivables
-113.64%-3K
-213.16%-43K
188.57%31K
146.15%6K
-90.63%3K
833.33%22K
392.31%38K
-141.18%-35K
86.32%-13K
60.00%32K
-Change in inventory
-389.29%-137K
-8.33%55K
-10.37%-181K
-208.89%-49K
22.58%38K
-121.37%-28K
850.00%60K
-500.00%-164K
-16.67%45K
-29.55%31K
-Change in prepaid assets
182.17%880K
211.05%593K
123.56%139K
0.00%113K
158.33%35K
-37.13%-1.07M
-65.33%-534K
-322.64%-590K
-85.40%113K
95.99%-60K
-Change in payables and accrued expense
63.89%4.87M
179.49%566K
176.95%3.41M
-70.75%1.09M
84.18%-202K
1,947.59%2.97M
-244.42%-712K
84.43%1.23M
378.31%3.73M
28.86%-1.28M
-Change in other current liabilities
15.64%-550K
-4.35%-144K
50.18%-139K
21.51%-135K
-109.52%-132K
5.92%-652K
22.03%-138K
-59.43%-279K
0.00%-172K
62.72%-63K
-Change in other working capital
-669.48%-15.43M
-17,183.12%-13.31M
10.21%-721K
-6.21%-667K
-47.28%-732K
4.80%-2.01M
12.50%-77K
-196.31%-803K
13.74%-628K
51.23%-497K
Cash from discontinued investing activities
Operating cash flow
3.15%-48.96M
83.23%-2.27M
-6.20%-14.55M
-52.14%-15.53M
-26.70%-16.62M
-9.61%-50.56M
-23.36%-13.54M
-33.24%-13.7M
2.71%-10.21M
8.81%-13.11M
Investing cash flow
Cash flow from continuing investing activities
-305.83%-26.94M
-371.94%-17.71M
-7,027.11%-38.58M
56.91%16.36M
121.79%13M
22.48%13.09M
-111.32%-3.75M
-95.70%557K
28.41%10.42M
113.46%5.86M
Net PPE purchase and sale
-69.20%-489K
68.87%-33K
-355.88%-310K
68.22%-34K
-1,300.00%-112K
-270.51%-289K
-3,633.33%-106K
-257.89%-68K
-296.30%-107K
77.14%-8K
Net investment purchase and sale
-289.21%-26.45M
-480.59%-17.68M
-6,223.84%-38.27M
55.64%16.39M
123.39%13.11M
29.87%13.98M
-109.19%-3.05M
-95.18%625K
29.29%10.53M
113.49%5.87M
Net other investing changes
----
----
----
----
----
---602K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-305.83%-26.94M
-371.94%-17.71M
-7,027.11%-38.58M
56.91%16.36M
121.79%13M
22.48%13.09M
-111.32%-3.75M
-95.70%557K
28.41%10.42M
113.46%5.86M
Financing cash flow
Cash flow from continuing financing activities
202.81%88.33M
-9.23%12.66M
408.13%76.4M
-350.29%-428K
-1,744.44%-296K
-36.88%29.17M
230.39%13.95M
375,775.00%15.04M
98.84%171K
-99.97%18K
Net issuance payments of debt
--0
----
----
----
----
238.26%15M
----
----
----
----
Net common stock issuance
294.57%59.32M
--1.54M
----
----
----
--15.04M
--0
----
----
----
Net preferred stock issuance
--12.56M
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-62.08%91K
--0
--0
--0
405.56%91K
-5.51%240K
-66.67%51K
--0
98.84%171K
63.64%18K
Net other financing activities
1,582.07%16.36M
---1.44M
--18.62M
---428K
---387K
-101.94%-1.1M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
202.81%88.33M
-9.23%12.66M
408.13%76.4M
-350.29%-428K
-1,744.44%-296K
-36.88%29.17M
230.39%13.95M
375,775.00%15.04M
98.84%171K
-99.97%18K
Net cash flow
Beginning cash position
-27.15%22.26M
64.08%42.01M
-20.93%18.75M
-21.33%18.35M
-27.15%22.26M
54.46%30.56M
34.21%25.61M
44.51%23.71M
24.76%23.32M
54.46%30.56M
Current changes in cash
249.78%12.43M
-118.96%-7.32M
1,129.55%23.26M
3.08%401K
45.92%-3.91M
-177.01%-8.3M
-129.13%-3.34M
-29.11%1.89M
117.02%389K
-564.37%-7.24M
End cash Position
55.83%34.69M
55.83%34.69M
64.08%42.01M
-20.93%18.75M
-21.33%18.35M
-27.15%22.26M
-27.15%22.26M
34.21%25.61M
44.51%23.71M
24.76%23.32M
Free cash flow
2.74%-49.45M
83.12%-2.3M
-7.93%-14.86M
-50.89%-15.56M
-27.48%-16.73M
-10.05%-50.85M
-24.36%-13.64M
-33.66%-13.77M
1.94%-10.31M
8.98%-13.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.15%-48.96M83.23%-2.27M-6.20%-14.55M-52.14%-15.53M-26.70%-16.62M-9.61%-50.56M-23.36%-13.54M-33.24%-13.7M2.71%-10.21M8.81%-13.11M
Net income from continuing operations 13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M
Operating gains losses ---254K------------------------------------
Depreciation and amortization 6.17%327K-2.38%82K6.58%81K9.46%81K12.16%83K7.32%308K16.67%84K7.04%76K1.37%74K4.23%74K
Other non cash items 757.92%2.06M19.52%1.19M957.33%643K194.84%147K115.46%81K107.80%240K308.82%994K91.35%-75K82.12%-155K39.42%-524K
Change In working capital -1,255.82%-10.37M-801.03%-12.28M497.65%2.54M-88.34%358K46.02%-990K76.87%-765K-1,075.00%-1.36M-204.24%-639K401.80%3.07M58.47%-1.83M
-Change in receivables -113.64%-3K-213.16%-43K188.57%31K146.15%6K-90.63%3K833.33%22K392.31%38K-141.18%-35K86.32%-13K60.00%32K
-Change in inventory -389.29%-137K-8.33%55K-10.37%-181K-208.89%-49K22.58%38K-121.37%-28K850.00%60K-500.00%-164K-16.67%45K-29.55%31K
-Change in prepaid assets 182.17%880K211.05%593K123.56%139K0.00%113K158.33%35K-37.13%-1.07M-65.33%-534K-322.64%-590K-85.40%113K95.99%-60K
-Change in payables and accrued expense 63.89%4.87M179.49%566K176.95%3.41M-70.75%1.09M84.18%-202K1,947.59%2.97M-244.42%-712K84.43%1.23M378.31%3.73M28.86%-1.28M
-Change in other current liabilities 15.64%-550K-4.35%-144K50.18%-139K21.51%-135K-109.52%-132K5.92%-652K22.03%-138K-59.43%-279K0.00%-172K62.72%-63K
-Change in other working capital -669.48%-15.43M-17,183.12%-13.31M10.21%-721K-6.21%-667K-47.28%-732K4.80%-2.01M12.50%-77K-196.31%-803K13.74%-628K51.23%-497K
Cash from discontinued investing activities
Operating cash flow 3.15%-48.96M83.23%-2.27M-6.20%-14.55M-52.14%-15.53M-26.70%-16.62M-9.61%-50.56M-23.36%-13.54M-33.24%-13.7M2.71%-10.21M8.81%-13.11M
Investing cash flow
Cash flow from continuing investing activities -305.83%-26.94M-371.94%-17.71M-7,027.11%-38.58M56.91%16.36M121.79%13M22.48%13.09M-111.32%-3.75M-95.70%557K28.41%10.42M113.46%5.86M
Net PPE purchase and sale -69.20%-489K68.87%-33K-355.88%-310K68.22%-34K-1,300.00%-112K-270.51%-289K-3,633.33%-106K-257.89%-68K-296.30%-107K77.14%-8K
Net investment purchase and sale -289.21%-26.45M-480.59%-17.68M-6,223.84%-38.27M55.64%16.39M123.39%13.11M29.87%13.98M-109.19%-3.05M-95.18%625K29.29%10.53M113.49%5.87M
Net other investing changes -----------------------602K----------------
Cash from discontinued investing activities
Investing cash flow -305.83%-26.94M-371.94%-17.71M-7,027.11%-38.58M56.91%16.36M121.79%13M22.48%13.09M-111.32%-3.75M-95.70%557K28.41%10.42M113.46%5.86M
Financing cash flow
Cash flow from continuing financing activities 202.81%88.33M-9.23%12.66M408.13%76.4M-350.29%-428K-1,744.44%-296K-36.88%29.17M230.39%13.95M375,775.00%15.04M98.84%171K-99.97%18K
Net issuance payments of debt --0----------------238.26%15M----------------
Net common stock issuance 294.57%59.32M--1.54M--------------15.04M--0------------
Net preferred stock issuance --12.56M------------------0----------------
Proceeds from stock option exercised by employees -62.08%91K--0--0--0405.56%91K-5.51%240K-66.67%51K--098.84%171K63.64%18K
Net other financing activities 1,582.07%16.36M---1.44M--18.62M---428K---387K-101.94%-1.1M----------------
Cash from discontinued financing activities
Financing cash flow 202.81%88.33M-9.23%12.66M408.13%76.4M-350.29%-428K-1,744.44%-296K-36.88%29.17M230.39%13.95M375,775.00%15.04M98.84%171K-99.97%18K
Net cash flow
Beginning cash position -27.15%22.26M64.08%42.01M-20.93%18.75M-21.33%18.35M-27.15%22.26M54.46%30.56M34.21%25.61M44.51%23.71M24.76%23.32M54.46%30.56M
Current changes in cash 249.78%12.43M-118.96%-7.32M1,129.55%23.26M3.08%401K45.92%-3.91M-177.01%-8.3M-129.13%-3.34M-29.11%1.89M117.02%389K-564.37%-7.24M
End cash Position 55.83%34.69M55.83%34.69M64.08%42.01M-20.93%18.75M-21.33%18.35M-27.15%22.26M-27.15%22.26M34.21%25.61M44.51%23.71M24.76%23.32M
Free cash flow 2.74%-49.45M83.12%-2.3M-7.93%-14.86M-50.89%-15.56M-27.48%-16.73M-10.05%-50.85M-24.36%-13.64M-33.66%-13.77M1.94%-10.31M8.98%-13.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More